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The popularity of NHCs in transition metal catalysis has prompted the development of chiral versions as
electron-rich neutral stereodirecting ancillary ligands for enantioselective transformations. Herein we
demonstrate that cyclic (alkyl)(amino)carbene (CAAC) ligands can also engage in asymmetric
transformations, thereby expanding the toolbox of available chiral carbenes.1. Introduction
The success of stable N-heterocyclic carbenes (NHCs) as ligands
for transition metal catalysts, and as organocatalysts in their
own right, has triggered the development of chiral versions.1–3
Surprisingly, as recently noted by Glorius and co-workers,4
despite the existence of a variety of stable heterocyclic car-
benes,5 only diaminocarbenes, namely imidazol-2-ylidenes,6
imidazolidin-2-ylidenes7 and 1,2,4-triazol-5-ylidenes8 have been
used as ligands for enantioselective transformations. In 2005
our group discovered cyclic (alkyl)(amino)carbenes (CAACs).9,10
We and others have demonstrated that their unique electronic
(more s-donating and p-accepting than NHCs) and steric
properties allow for the improvement of known catalytic
processes (Ru,11 Pd,9,12 and Rh13) as well as promoting novel
reactions with coinage metals (Cu14 and Au15). The direct
protonated precursors of CAACs are readily available in one pot
from an aldehyde and a primary amine (Scheme 1(1)).16We have
shown that our versatile synthetic methodology facilitates
access to a library of 5-membered (CAAC-5), 6-membered
(CAAC-6),12 bicylic (BiCAAC)17 and even bifunctional CAACs
(FunCAAC)14b (Scheme 1(2)). Of particular importance, the
CAAC family features a quaternary carbon adjacent to the car-
bene carbon, thus allowing the introduction of a chiral center in
closer proximity to the active site than NHCs. Herein, we reportennes, Univ Rennes, CNRS, ISCR – UMR
.mauduit@ensc-rennes.fr
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hemistry 2019the rst examples of chiral CAAC ligands in asymmetric
catalysis.
In our initial paper on CAACs,9 we showed that the enan-
tiopure L-MenthCAAC could be prepared without time-
consuming enantio- or diastereoselective separation from the
inexpensive ()-menthol (Scheme 2). The key step of the
synthesis was based on the well-known propensity of relatively
bulky reactants to approach the cyclohexane moiety selectively
from the equatorial direction.2. Results and discussion
Years ago, we tested L-MenthCAAC transition metal complexes in
a variety of asymmetric catalytic reactions without any success.
Given our recent mechanistic work on copper-catalysis, we
decided to revive this topic. We considered benchmarking the
L-MenthCAAC in the copper-catalysed Asymmetric Conjugate
Borylation (ACB) reaction. Over the past decade, this chemical
transformation has emerged as a stalwart method for the
preparation of chiral organoboron building blocks, which areScheme 1 Synthetic route to cyclic (alkyl)(amino)carbenes, and
existing families of CAACs.
Chem. Sci., 2019, 10, 7807–7811 | 7807
Scheme 2 Synthesis of L-MenthCAAC highlighting the key step. Scheme 4 Conformational inversion of the menthyl ring.23
Fig. 1 Proposed justification for the lack of asymmetric induction in
catalyst 1.




























































































View Article Onlinesought aer in organic synthesis.18 Although pioneered by Yun19
and others using chiral phosphine ligands,18d Ferna´ndez,20
Hoveyda21 and others18d have successfully shown that carbene
ligands, specically NHCs, could also be utilized in this process.
As can be seen in Scheme 3, although the L-MenthCAAC
copper complex 1 was found to be highly active in the addition
of bis(pinacolato)diboron (B2pin2) to various a,b-unsaturated
esters, an almost complete lack of asymmetric induction was
observed. In comparison, the known non C2-chiral NHC copper
complex 2,22 derived from (S)-1-(naphthalen-1-yl)ethan-1-amine,
gave a 55% ee for the borylated adduct P1. Examining the X-ray
crystal structure of 1,9 we expected some asymmetric induction
since for many years we believed that a conformational inver-
sion of the menthyl ring was energetically inaccessible.
However, we recently found that in the solid state the menthyl
group of the L-MenthCAAC amine adduct L-MenthCAACNH existed
as the other conformer with the methyl and isopropyl substit-
uents in axial position (Scheme 4).23 We were able to conrm
with DFT calculations that the inverted menthyl conformer is
also readily accessible in complex 1 (Fig. 1). The existence of the
two conformers 1 and 10 readily explains the lack of asymmetric
induction since they have antagonistic stereo-inducing effects.
To circumvent this issue, we sought to prepare a more rigid
chiral CAAC. Among the number of readily available molecules
derived from the chiral pool, we selected the steroid backbone
for its bulk, structural diversity, and tunability. We also
reasoned that owing to a three-dimensional skeleton composed
of four fused rings (three six-member cyclohexane rings – A, B,
C- and one ve-member cyclopentane ring D), this steroid motifScheme 3 Comparing L-MenthCAACCuCl 1 and NHC–CuCl 2 in the
Asymmetric Conjugate Borylation (ACB) reaction. aDetermined by 1H
NMR spectroscopy using mesitylene as an internal standard. bIsolated
yield after SiO2 purification.
cDetermined by GC on a chiral stationary
phase (see ESI for details†).
7808 | Chem. Sci., 2019, 10, 7807–7811would provide the desired rigid structural features while
keeping the chirality intact during the synthesis (Fig. 2).
Before proceeding further, we conrmed that our synthetic
methodology16 extends to the readily available decahy-
dronaphthalene, a model substrate mimicking the rst two
fused cyclohexane (A and B) rings of a steroid skeleton (Scheme
5). CAAC-decahydronaphthyl iminium rac-NaphCAAC was ob-
tained in 7 steps and 50% yield as a white powder.
Reassured by these results, we applied the same synthetic
strategy to 5a-cholestan-3-one, an inexpensive enantiopureFig. 2 Steroid CAACs as versatile chiral ligand frameworks.
Scheme 5 Preparation of rac-NaphCAAC.
This journal is © The Royal Society of Chemistry 2019
Scheme 6 Preparation of CholestCAAC and complex 3. Scheme 7 Evaluation of CholestCAACCuCl complex 3 in ACB reaction.
aDetermined by 1H NMR spectroscopy using mesitylene as an internal
standard. bIsolated yield after SiO2 purification.
cDetermined by GC on
a chiral stationary phase (see ESI for details†). dAnthracene was used as
internal standard.




























































































View Article Onlinesteroid derived from coprostanol (Scheme 6). The CAAC-
cholestanyl iminium CholestCAAC was obtained in 6 steps and
63% yield as a white uffy powder.24 The corresponding copper
complex 3 was prepared by deprotonation of the CholestCAAC
iminium with KHDMS followed by addition of copper chloride
in THF. Single crystals were obtained by slow diffusion of
diethyl ether in acetonitrile, and an X-ray diffraction study
conrmed the formation of CholestCAACCuCl complex 3 (Fig. 3).
It crystallized in the P21 space group with one molecule in the
asymmetric unit cell.
The absolute stereochemistry was conclusively established
using anomalous dispersion with a Flack parameter of 0.002(7)Fig. 3 X-ray crystal structure of 3 (top) with the side-on orientation
(omitting hydrogen for clarity) and an overlaid topological steric map
with a quadrant diagram.
This journal is © The Royal Society of Chemistry 2019from renement. The X-ray data of 3 show a distinctive orien-
tation of the cholestanyl backbone, which gives rise to the
topographic steric map showed in Fig. 3.25,26 As can be seen, the
corresponding quadrant diagram could support facial stereo-
selectivity in catalyst-substrate adducts.
We next evaluated complex 3 in the ACB reaction (Scheme 7).
As with L-MenthCAACCuCl 1, the steroid copper complex Choles-
tCAACCuCl 3 efficiently catalyzes the addition of B2pin2 to
various b-substituted a,b-unsaturated esters, affording the cor-
responding 1,4-adducts in moderate to good isolated yields (47
to 77%). More importantly, we were pleased to observe enantio-
inductions with enantioselectivities reaching 55%.
3. Conclusions
This work rationalizes the inability of L-MenthCAAC to induce
enantiomeric excess, and indicates that upon providing the
right steric environment, the use of chiral CAACs should not be
overlooked in metal-catalyzed asymmetric transformations.
This new family of stereo-directing chiral carbene ligands are
readily available from inexpensive precursors belonging to the
chiral pool, and it is noteworthy that the chirality is not
restricted to chiral amines (as is the case of NHCs), but extends
to chiral aldehydes, a much larger feedstock.
Conflicts of interest
There are no conicts to declare.
Acknowledgements
This work was supported by the U.S. Department of Energy,
Office of Science, Basic Energy Sciences, Catalysis Science
Program, under Award # DE-SC0009376, and the Agence
Nationale de la Recherche (ANR-16-CE07-0019 – Hel-NHC)Chem. Sci., 2019, 10, 7807–7811 | 7809




























































































View Article OnlineThanks are due to the Alfred P. Sloan Foundation's University
Centre for Exemplary Mentoring and the National Science
Foundation Graduate Research Fellowship Program under
Grant No. DGE-1650112 (G. P. J.), and to the National Science
Foundation (V. L. – Grant # CHE-1455348). Any opinions, nd-
ings, and conclusions or recommendations expressed in this
material are those of the author(s) and do not necessarily reect
the views of the National Science Foundation. We also greatly
acknowledge the Region Bretagne for the ARED 2018, (“Bio-
meta”, N 601), and Rennes-Metropole for supporting interna-
tional PhD mobility (D. P.). MM and TV thank Shimadzu and
Chiral Technology for their support in the separation of chiral
molecules by Supercritical Fluid Chromatography (SFC)
technology.
Notes and references
1 (a) J. C. Sheehan and D. H. Hunneman, J. Am. Chem. Soc.,
1966, 88, 3666–3667; (b) D. Enders, H. Gielen, G. Raabe,
J. Runsink and J. H. Teles, Chem. Ber., 1996, 129, 1483–
1488; (c) W. A. Herrmann, L. J. Goossen, C. Ko¨cher and
G. R. J. Artus, Angew. Chem., Int. Ed., 1996, 35, 2805–2807;
(d) M. T. Powell, D. R. Hou, M. C. Perry, X. Cui and
K. Burgess, J. Am. Chem. Soc., 2001, 123, 8878–8879; (e)
T. J. Seiders, D. W. Ward and R. H. Grubbs, Org. Lett.,
2001, 3, 3225–3228.
2 For reviews: (a) F. Wang, L.-J. Liu, W. Wang, S. Li and M. Shi,
Coord. Chem. Rev., 2012, 256, 804–853; (b) M. Zhao,
Y.-T. Zhang, J. Chen and L. Zhou, Asian J. Org. Chem., 2018,
7, 54–69; (c) J. Ouyang and J. Crassous, Coord. Chem. Rev.,
2018, 376, 533–547; (d) D. M. Flanigan, F. Romanov-
Michailidis, N. A. White and T. Rovis, Chem. Rev., 2015,
115, 9307–9387; (e) A. Grossmann and D. Enders, Angew.
Chem., Int. Ed., 2012, 51, 314–325.
3 Selected examples of chiral NHC in: – Au catalysis – (a)
Y.-M. Wang, C. N. Kuzniewski, V. Rauniyar, C. Hoong and
F. D. Toste, J. Am. Chem. Soc., 2011, 133, 12972–12975; (b)
Y. Matsumoto, K. B. Selim, H. Nakanishi, K. Yamada,
Y. Yamamoto and K. Tomioka, Tetrahedron Lett., 2010, 51,
404–406; (c) C. Bartolome, D. Garc´ıa-Cuadrado, Z. Ramiro
and P. Espinet, Inorg. Chem., 2010, 49, 9758–9764; (d)
S. Handa and L. M. Slaughter, Angew. Chem., Int. Ed., 2012,
51, 2912–2915; – Cu catalysis – ; (e) S. Drissi-Amraoui,
M. Morin, C. Cre´visy, O. Basle´, R. Marcia de Figueiredo,
M. Mauduit and J.-M. Campagne, Angew. Chem., Int. Ed.,
2015, 54, 11830–11834; – Pd catalysis – ; (f) E. P. Ku¨ndig,
T. M. Seidel, Y. X. Jia and G. Bernardinelli, Angew. Chem.,
Int. Ed., 2007, 46, 8484–8487; – Rh catalysis – ; (g)
J. H. Kim, S. Greßies, M. Boultadakis-Arapinis, C. Daniliuc
and F. Glorius, ACS Catal., 2016, 6, 7652–7656. – Ru
catalysis – ; (h) A. Kannenberg, D. Rost, S. Eibauer, S. Tiede
and S. Blechert, Angew. Chem., Int. Ed., 2011, 50, 3299–3302.
4 D. Janssen-Mueller, C. Schlepphortst and F. Glorius, Chem.
Soc. Rev., 2017, 46, 4845–4854.
5 For reviews, see: (a) A. Vivancos, C. Segarra and M. Albrecht,
Chem. Rev., 2018, 118, 9493–9586; (b) G. Guisado-Barrios,
M. Soleilhavoup and G. Bertrand, Acc. Chem. Res., 2018, 51,7810 | Chem. Sci., 2019, 10, 7807–78113236–3244; (c) M. Melaimi, M. Soleilhavoup and
G. Bertrand, Angew. Chem., Int. Ed., 2010, 49, 8810–8849.
6 A. J. Arduengo III, R. L. Harlow and M. Kline, J. Am. Chem.
Soc., 1991, 113, 361–363.
7 A. J. Arduengo III, J. R. Goerlich and W. J. Marshall, J. Am.
Chem. Soc., 1995, 117, 11027–11028.
8 D. Enders, K. Breuer, G. Raabe, J. Runsink, J. H. Teles,
J. P. Melder, K. Ebel and S. Brode, Angew. Chem., Int. Ed.,
1995, 34, 1021–1023.
9 V. Lavallo, Y. Canac, C. Pra¨sang, B. Donnadieu and
G. Bertrand, Angew. Chem., Int. Ed., 2005, 44, 5705–5709.
10 For reviews on CAACs see: (a) M. Melaimi, R. Jazzar,
M. Soleihavoup and G. Bertrand, Angew. Chem., Int. Ed.,
2017, 56, 10046–10068; (b) M. Soleilhavoup and
G. Bertrand, Acc. Chem. Res., 2015, 48, 256–266; (c)
M. Melaimi, M. Soleilhavoup and G. Bertrand, Angew.
Chem., Int. Ed., 2010, 49, 8810–8849; (d) S. Roy,
K. C. Mondal and H. W. Roesky, Acc. Chem. Res., 2016, 49,
357–369; (e) U. S. D. Paul and U. Radius, Eur. J. Inorg.
Chem., 2017, 3362–3375.
11 (a) V. M. Marx, A. H. Sullivan, M. Melaimi, S. C. Virgil,
B. K. Keitz, D. S. Weinberger, G. Bertrand and
R. H. Grubbs, Angew. Chem., Int. Ed., 2014, 54, 1919–1923;
(b) D. R. Anderson, V. Lavallo, D. J. O'leary, G. Bertrand
and R. H. Grubbs, Angew. Chem., Int. Ed., 2007, 46, 7262–
7265; (c) D. R. Anderson, T. Ung, G. Mkrtumyan,
G. Bertrand, R. H. Grubbs and Y. Schrodi, Organometallics,
2008, 27, 563–566; (d) V. M. Marx, A. H. Sullivan,
M. Melaimi, S. C. Virgil, B. K. Keitz, D. S. Weinberger,
G. Bertrand and R. H. Grubbs, Angew. Chem., Int. Ed.,
2015, 54, 1919–1923.
12 C. M. Weinstein, G. P. Junor, D. R. Tolentino, R. Jazzar,
M. Melaimi and G. Bertrand, J. Am. Chem. Soc., 2018, 140,
9255–9260.
13 (a) M. P. Wiesenfeldt, Z. Nairoukh, W. Li and F. Glorius,
Science, 2017, 357, 908–912; (b) Y. Wei, B. Rao, X. Cong
and X. Zeng, J. Am. Chem. Soc., 2015, 137, 9250–9253; (c)
L. Tran, J. L. Fulton, J. C. Linehan, M. Balasubramanian,
J. A. Lercher and R. M. Bullock, ACS Catal., 2019, 9, 4106–
4114; (d) Z. Nairoukh, M. Wollenburg, C. Schlepphorst,
K. Bergander and F. Glorius, Nat. Chem., 2019, 11, 264–270.
14 (a) E. A. Romero, R. Jazzar and G. Bertrand, Chem. Sci., 2017,
8, 165–168; (b) J. Chu, D. Munz, R. Jazzar, M. Melaimi and
G. Bertrand, J. Am. Chem. Soc., 2016, 138, 7884–7887.
15 (a) X. Hu, D. Martin, M. Melaimi and G. Bertrand, J. Am.
Chem. Soc., 2014, 136, 13594–13597; (b) R. Kinjo,
B. Donnadieu and G. Bertrand, Angew. Chem., Int. Ed.,
2011, 50, 5560–5563; (c) X. Zeng, R. Kinjo, B. Donnadieu
and G. Bertrand, Angew. Chem., Int. Ed., 2010, 49, 942–945;
(d) V. Lavallo, G. D. Frey, B. Donnadieu, M. Soleilhavoup
and G. Bertrand, Angew. Chem., Int. Ed., 2008, 47, 5224–
5228; (e) L. Jin, D. S. Weinberger, M. Melaimi, C. E. Moore,
A. L. Rheingold and G. Bertrand, Angew. Chem., Int. Ed.,
2014, 53, 9059–9063.
16 (a) R. Jazzar, H. Liang, B. Donnadieu and G. Bertrand, J.
Organomet. Chem., 2006, 691, 3201–3205; (b) R. Jazzar,
R. D. Dewhurst, J.-B. Bourg, B. Donnadieu, Y. Canac andThis journal is © The Royal Society of Chemistry 2019




























































































View Article OnlineG. Bertrand, Angew. Chem., Int. Ed., 2007, 46, 2899–2902; (c)
R. Jazzar, J.-B. Bourg, R. D. Dewhurst, B. Donnadieu and
G. Bertrand, J. Org. Chem., 2007, 72, 3492–3499; (d)
X. Zeng, G. D. Frey, R. Kinjo, B. Donnadieu and
G. Bertrand, J. Am. Chem. Soc., 2009, 131, 8690–8696.
17 E. Toma´s-Mendivil, M. M. Hansmann, C. M. Weinstein,
R. Jazzar, M. Melaimi and G. Bertrand, J. Am. Chem. Soc.,
2017, 139, 7753–7756.
18 (a) J. A. Schiffner, K. Muther andM. Oestreich, Angew. Chem.,
Int. Ed., 2010, 49, 1194–1196; (b) E. C. Neeve, S. J. Geier,
I. A. Mkhalid, S. A. Westcott and T. B. Marder, Chem. Rev.,
2016, 116, 9091–9161; (c) Q. Liu, B. Tian, P. Tian, X. Tong
and G.-Q. Lin, Chin. J. Org. Chem., 2015, 35, 1–14; (d)
K. Zheng, X. Liu and X. Feng, Chem. Rev., 2018, 118, 7586–
7656.
19 (a) J. E. Lee and J. Yun, Angew. Chem., Int. Ed., 2008, 47, 145–
147; (b) H. Chea, H.-S. Sim and J. Yun, Adv. Synth. Catal.,
2009, 351, 855–858; (c) H. S. Sim, X. Feng and J. Yun,
Chem.–Eur. J., 2009, 15, 1939–1943; (d) X. Feng and J. Yun,
Chem. Commun., 2009, 6577–6579.
20 V. Lillo, A. Prieto, A. Bonet, M. M. D´ıaz-Requejo, J. Ramı´rez,
P. J. Pe´rez and E. Fernan´dez, Organometallics, 2009, 28, 659–
662.
21 J. M. O'Brien, K. S. Lee and A. H. Hoveyda, J. Am. Chem. Soc.,
2010, 132, 10630–10633.This journal is © The Royal Society of Chemistry 201922 (a) C. Jahier-Diallo, M. S. T. Morin, P. Queval, M. Rouen,
I. Artur, P. Querard, L. Toupet, C. Cre´visy, O. Basle´ and
M. Mauduit, Chem.–Eur. J., 2015, 21, 993–997. For a higher
ee, see: ; (b) J. K. Park, H. H. Lackey, M. D. Rexford,
K. Kovnir, M. Shatruk and D. T. McQuade, Org. Lett., 2010,
12, 5008–5011.
23 D. Tolentino, S. Neale, C. Isaac, S. Macgregor, M. Whittlesey,
R. Jazzar and G. Bertrand, J. Am. Chem. Soc., 2019, 141, 9823–
9826.
24 Cholesterol derived NHCs have been reported: (a) L. Rakers,
L. M. Mart´ınez-Prieto, A. M. Lo´pez-Vinasco, K. Philippot,
P. W. N. M. van Leeuwen, B. Chaudret and F. Glorius,
Chem. Commun., 2018, 54, 7070–7073; (b) L. Rakers,
D. Grill, A. L. L. Matos, S. Wulff, D. Wang, J. Bo¨rgel,
M. Ko¨rsgen, H. F. Arlinghaus, H.-J. Galla, V. Gerke and
F. Glorius, Cell Chem. Biol., 2018, 25, 952–961.
25 H. Clavier and S. P. Nolan, Chem. Commun., 2010, 46, 841–
861.
26 Steric maps were extrapolated using the SambVca 2 web-
based program developed by Cavallo and co-workers.
F. Falivene, R. Credendino, A. Poater, A. Petta, L. Serra,
R. Oliva, V. Scarano and L. Cavallo, Organometallics, 2016,
35, 2286–2293.Chem. Sci., 2019, 10, 7807–7811 | 7811
